Metraipolis › archive › dc_fd0c36d76bbe

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen — Europe PMC PMID:33841165

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/33841165
DOI
10.3389/fphar.2021.646676
License (as archived)
solo-consultazione
Archived
2026-10-08T03:01:50.632Z
SHA-256 of the archived text
2addc90d7af460564f202ca740328b37a1e7be07da7b932b42fe05947311dc0e
Stable URL of this page
https://metraipolis.com/documento/dc_fd0c36d76bbe

How to cite

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen — Europe PMC PMID:33841165 — Europe PMC (en), https://europepmc.org/article/MED/33841165 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd0c36d76bbe (Metraipolis archive dc_fd0c36d76bbe, sha256 2addc90d7af460564f202ca740328b37a1e7be07da7b932b42fe05947311dc0e)
BibTeX
@misc{dcfd0c36d76bbe,
  title = {Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen — Europe PMC PMID:33841165},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/33841165},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd0c36d76bbe; sha256 2addc90d7af460564f202ca740328b37a1e7be07da7b932b42fe05947311dc0e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/33841165. Agents can read the archived copy with the MCP tool read_document.